Skip to content

Sterile Compounding Start to Finish

Pharmacists who oversee and/or participate in sterile compounding should be knowledgeable about current relevant best practices and procedures. Regulations relevant to USP <797> are proposed and updated regularly requiring that those who practice in the sterile compounding setting are knowledgeable in the most current proposed and/or enforced regulations, and are meeting compliance in practice.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Employ proper techniques to ensure sterility and quality of compounded pharmaceutical products.
  • Demonstrate appropriate hand hygiene techniques and proper use and disposal of Personal Protective Equipment (PPE).
  • Describe personnel required trainings for compounding sterile products.


Merritt Nettles, PharmD
Merritt Nettles, PharmD graduated from Campbell University in 2019 with a dual doctor of pharmacy and masters of business administration degree. Merritt is a second year post-doctoral Regulatory Affairs fellow at Novartis Institutes for BioMedical Research, where he focuses on early drug development as a regulatory affairs associate, concentrating in the therapeutic areas of oncology and cardio metabolic diseases.

Anna Orbite, PharmD
Anna Orbite, PharmD graduated from MCPHS University in Boston in 2020. She is currently a post-doctoral fellow in Regulatory Affairs through the Novartis Institutes for BioMedical Research/MCPHS University fellowship program.


ACPE logo

Release Date: November 17, 2020
Expiration Date: November 18, 2021
Contact Hours: 1.0
Universal Activity Number: 0026-0000-20-022-H03-P | Knowledge-based
ACPE Topic Designator: Law

Registration is free.